David G. Booth

Solomon Partners Welcomes Solange Velazquez as Managing Director in the Technology Group

Retrieved on: 
Mardi, juin 4, 2024

NEW YORK and CHICAGO, June 04, 2024 (GLOBE NEWSWIRE) -- Solomon Partners announced that Solange Velazquez has joined the firm as a Managing Director in the Technology Group .

Key Points: 
  • NEW YORK and CHICAGO, June 04, 2024 (GLOBE NEWSWIRE) -- Solomon Partners announced that Solange Velazquez has joined the firm as a Managing Director in the Technology Group .
  • Ms. Velazquez brings significant experience from her previous position as Managing Director in the Technology Investment Banking group at William Blair & Company, where she spent 12 years advising clients on M&A transactions.
  • Ms. Velazquez was selected as one of the “2023 Most Influential Women in Mid-Market M&A” by Mergers & Acquisitions magazine.
  • “Solange’s extensive experience and proven track record in technology investment banking will be invaluable as we continue to grow and strengthen our Technology group and expand into new sub-sectors."

Mawson Infrastructure Group Announces Hiring of Head of Corporate Strategy and Head of Corporate Development

Retrieved on: 
Jeudi, mai 9, 2024

MIDLAND, Pa., May 09, 2024 (GLOBE NEWSWIRE) -- Mawson Infrastructure Group Inc. (NASDAQ: MIGI) (“Mawson,” or “the Company”), a digital infrastructure company, today announced that it has named Anurag Gandhi as Head of Corporate Strategy, and Vikram Murali as Head of Corporate Development, to enhance Mawson’s continued focus and transformation, strategic growth initiatives, and future ecosystem consolidation opportunities.

Key Points: 
  • MIDLAND, Pa., May 09, 2024 (GLOBE NEWSWIRE) -- Mawson Infrastructure Group Inc. (NASDAQ: MIGI) (“Mawson,” or “the Company”), a digital infrastructure company, today announced that it has named Anurag Gandhi as Head of Corporate Strategy, and Vikram Murali as Head of Corporate Development, to enhance Mawson’s continued focus and transformation, strategic growth initiatives, and future ecosystem consolidation opportunities.
  • Mr. Gandhi commented, “Joining Mawson at this pivotal juncture presents a unique opportunity to contribute to the Company's ongoing transformation.
  • Mr. Murali was most recently an investment banker with Evercore, a global investment bank, with their M&A advisory practice.
  • Mr. Murali commented, “I am excited to join Mawson during this pivotal time for both the Company and the industry.

Lincoln Private Market Index Continued to Climb in the First Quarter on the Back of Steady Earnings Growth

Retrieved on: 
Mardi, mai 7, 2024

For the 12th consecutive quarter, the index’s growth was primarily driven by positive financial performance rather than multiple expansion.

Key Points: 
  • For the 12th consecutive quarter, the index’s growth was primarily driven by positive financial performance rather than multiple expansion.
  • For the fourth consecutive quarter, the percentage of companies achieving LTM EBITDA growth increased, with 63.0% of companies tracked by Lincoln demonstrating EBITDA growth in the first quarter.
  • Two-thirds of private market participants surveyed by Lincoln International in Q1 2024 indicated an expectation that private company M&A activity would resume in the next six months.
  • Notably, the Lincoln Senior Debt Index (LSDI) increased to 98.4% from 97.9% at the end of 2023 reflecting these trends.

Rodney Jones-Tyson joins Associated Banc-Corp Board of Directors

Retrieved on: 
Mardi, avril 30, 2024

GREEN BAY, Wis., April 30, 2024 /PRNewswire/ -- Associated Banc-Corp (NYSE: ASB) ("Associated") today announced that Rodney Jones-Tyson has been elected to its Board of Directors at the Annual Meeting of Shareholders.

Key Points: 
  • GREEN BAY, Wis., April 30, 2024 /PRNewswire/ -- Associated Banc-Corp (NYSE: ASB) ("Associated") today announced that Rodney Jones-Tyson has been elected to its Board of Directors at the Annual Meeting of Shareholders.
  • Jones-Tyson is the global chief human resources officer of Robert W. Baird & Co.
  • "I look forward to partnering with him moving forward on Associated's strategic planning and future growth."
  • Since 2022, Jones-Tyson has served as a member of the Board of Trustees of Investors Real Estate Trust, dba, Centerspace, where he serves as chair of the Compensation Committee.

Genstar Names Keith Martino to Strategic Advisory Board

Retrieved on: 
Mardi, avril 30, 2024

SAN FRANCISCO, April 30, 2024 /PRNewswire/ -- Genstar Capital, a leading private equity firm focused on investments in targeted segments of the healthcare, financial services, industrials, and software industries, today announced the appointment of experienced pharma executive Keith Martino to its team of operational experts serving on its Strategic Advisory Board. He will advise the Genstar team in its healthcare vertical.

Key Points: 
  • SAN FRANCISCO, April 30, 2024 /PRNewswire/ -- Genstar Capital, a leading private equity firm focused on investments in targeted segments of the healthcare, financial services, industrials, and software industries, today announced the appointment of experienced pharma executive Keith Martino to its team of operational experts serving on its Strategic Advisory Board.
  • Scott Niehaus, Director of Genstar Capital, said, "Keith is highly regarded in the pharma industry and has extensive background across the value chain including working with private equity.
  • We look forward to Keith's guidance in evaluating new healthcare investment opportunities and advising portfolio companies as a board member."
  • Mr. Martino was named to the Board of Genstar portfolio company Signant Health.

HEARTWOOD APPOINTS THREE AS MANAGING PARTNERS

Retrieved on: 
Lundi, avril 29, 2024

NORWALK, Conn., April 29, 2024 /PRNewswire/ -- Heartwood Partners, LLC ("Heartwood") is pleased to announce the promotions of Demetrios Dounis, James Sidwa and Edwin ("Ed") Tan to Managing Partners of the firm.

Key Points: 
  • NORWALK, Conn., April 29, 2024 /PRNewswire/ -- Heartwood Partners, LLC ("Heartwood") is pleased to announce the promotions of Demetrios Dounis, James Sidwa and Edwin ("Ed") Tan to Managing Partners of the firm.
  • Heartwood Partners promotes Demetrios Dounis, James Sidwa, and Edwin Tan to Managing Partners of the firm.
  • Rob noted, "All three individuals have demonstrated strong investment results and leadership as Partners of the firm and as members of the Investment Committee.
  • The three new Managing Partners have over 65 years of collective financial experience and have displayed consistent investment acumen through numerous business cycles.

The Joint Commission Enterprise Announces Four Appointments to Executive Leadership Team

Retrieved on: 
Jeudi, avril 11, 2024

“As The Joint Commission continues to embark on its journey of transformation, I am pleased to welcome these four dynamic leaders,” says Jonathan B. Perlin, MD, PhD, president and CEO, The Joint Commission enterprise.

Key Points: 
  • “As The Joint Commission continues to embark on its journey of transformation, I am pleased to welcome these four dynamic leaders,” says Jonathan B. Perlin, MD, PhD, president and CEO, The Joint Commission enterprise.
  • She was previously at the American Society of Anesthesiologists (ASA), where she served as the financial and revenue officer.
  • She also held senior roles in finance, operations, business intelligence and analytics at Navigant Consulting, Aon Hewitt, AT&T and CDK Global.
  • Serving as the key liaison between The Joint Commission and the healthcare safety community, she will help design services to further enhance quality and safety.

Anzu Partners Promotes Three Business Services Team Members to Principal

Retrieved on: 
Mardi, avril 23, 2024

Anzu Partners , an investment firm delivering capital and strategic support to breakthrough technology companies, announced the promotion of three team members to Principal across its business services teams:

Key Points: 
  • Anzu Partners , an investment firm delivering capital and strategic support to breakthrough technology companies, announced the promotion of three team members to Principal across its business services teams:
    This press release features multimedia.
  • View the full release here: https://www.businesswire.com/news/home/20240423119701/en/
    Anzu Partners Promotes Patrick Harrington, Kyle McQuighan, and Wendy Papakostandini to Principal.
  • Wendy Papakostandini, who leads talent for Anzu and whose team placed over 100 candidates in 2023.
  • Prior to Anzu, Kyle led business development for a top 100 CPA firm Aronson’s technology, life science, venture fund, and government contracting practices.

The Arena Group Appoints Sara Silverstein as Chief Executive Officer

Retrieved on: 
Lundi, avril 22, 2024

On April 19, 2024, the Board of Directors of The Arena Group Holdings, Inc. (NYSE American: AREN) appointed Sara Silverstein as the Company’s Chief Executive Officer, effective immediately.

Key Points: 
  • On April 19, 2024, the Board of Directors of The Arena Group Holdings, Inc. (NYSE American: AREN) appointed Sara Silverstein as the Company’s Chief Executive Officer, effective immediately.
  • View the full release here: https://www.businesswire.com/news/home/20240422547644/en/
    Sara Silverstein, New Arena Group Chief Executive Officer (Photo: Business Wire)
    Silverstein joined Arena Group to manage TheStreet in 2021.
  • “Sara has led one of the fastest-growing, most innovative and profitable sectors within the Company,” said Cavitt Randall, former CEO.
  • “The Arena Group is poised for exceptional growth in this evolving media landscape,” said Silverstein.

Actym Therapeutics Appoints Thomas Smart as CEO

Retrieved on: 
Mercredi, avril 24, 2024

BERKELEY, Calif., April 24, 2024 /PRNewswire/ -- Actym Therapeutics , pioneering a new drug modality to treat solid tumors, announced today the appointment of Thomas Smart as Chief Executive Officer.

Key Points: 
  • BERKELEY, Calif., April 24, 2024 /PRNewswire/ -- Actym Therapeutics , pioneering a new drug modality to treat solid tumors, announced today the appointment of Thomas Smart as Chief Executive Officer.
  • The STACT approach provides both efficacy and safety advantages by leveraging a genetically modified bacteria vehicle, systemically administered, that achieves tissue-specific delivery of large nucleic acid payloads," said Thomas Smart, CEO of Actym.
  • Mr. Smart has a distinguished 25-year career as a biotech executive, demonstrating dynamic leadership in roles such as CEO, CBO, SVP, and Board Member.
  • Before joining Actym Therapeutics, Mr. Smart founded Gravitas Therapeutics, where he served as CEO and Board Chair and orchestrated the acquisition and subsequent sale of the clinical-stage antifungal asset, GR-2397, to Basilea Pharmaceutica Ltd (SIX: BSLN) in October 2023.